“Magic mushrooms” have officially entered the mainstream. Proponents in the media now regularly extol their potential for alleviating depression, addiction, and a host of other mental health issues, often linking their ongoing prohibition to a government PR blitz in the 60s and 70s. Today, psilocybin is the most commonly used psychedelic among people 34 and younger.
Let’s take a closer look at psilocybin
atai Life Sciences acquires majority stake in Psyber, Inc., to develop Brain Computer Interface-enabled digital therapeutics targeting mental health disorders
atai Life Sciences, a global biopharmaceutical company developing psychedelic and non-psychedelic compounds for various mental health indications, has acquired a…
JOIN THE ATAI #INSIGHTNETWORK